Table 6.
Association between serum albumin levels and cancer mortality in rare cancer types.
| Groups | N | Cancer mortality (Per 1g/dL albumin decrease) | |||
|---|---|---|---|---|---|
| Crude HR (95% CI) |
P
for trend |
Adjusted HR (95% CI) |
P
for trend |
||
| Cervix | 303 | 0.95 (0.36, 2.51) | 0.930 | 1.07 (0.26, 4.48) | 0.921 |
| Uterus | 180 | 2.04 (0.92, 4.55) | 0.143 | 2.16 (0.78, 6.06) | 0.143 |
| Bladder | 107 | 1.82 (0.82, 4.04) | 0.144 | 0.93 (0.30, 2.94) | 0.903 |
| Ovary | 100 | 3.45 (1.50, 7.69) | 0.003 | 3.33 (0.70, 9.64) | 0.132 |
| Lymphoma | 83 | 5.55 (1.59, 11.07) | 0.007 | 3.03 (0.43, 20.12) | 0.273 |
| Kidney | 81 | 2.17 (0.72, 6.36) | 0.170 | 3.63 (0.78, 14.28) | 0.104 |
Crude model: adjusted for none. Adjusted model: adjusted for age, sex, ethnicity, BMI, smoking, drinking, hypertension, diabetes mellitus, anemia, CVD. HR, Hazard ratio and CI, confidence interval.